TGA lists Wegovy tablets


Regulator approves Australia's first oral GLP-1 for weight management Tablet preparations of Novo Nordisk's Wegovy (semaglutide) are set to become available to Australian patients, after the Therapeutic Goods Administration (TGA) gave the green light for theme to be listed on the Australian Register of Therapeutic Goods (ARTG).   The regulator has approved the listing of the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Eye care: looking beyond the presentation
Next New sodium valproate in pregnancy guidance